Ronald Simon

University Medical Center Hamburg-Eppendorf

Research Interests

Explore related searches

Contact this professor

Google Scholar

Articles (26)

Collaborators (8)

Nikolaj Frost

Charité Universitätsmedizin Berlin - Campus Virchow-Klinikum

Eik Vettorazzi

University Medical Center Hamburg-Eppendorf

Sarah Weinberger

Charité - Universitätsmedizin Berlin

Maximilian Lennartz

University Medical Center Hamburg-Eppendorf

Karsten Rippe

Head of Division

German Cancer Research Center (DKFZ)

Aria Baniahmad

Tarik Ghadban

University Medical Center Hamburg-Eppendorf

Niclas Christian Blessin

University Medical Center Hamburg-Eppendorf

Ronald Simon

Research Interests

Explore related searches

Contact this professor

Articles (26)

Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomy.

Patient‐derived tumor organoids highlight the potential of precision medicine in managing pancreatic ductal adenocarcinoma

HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor Phenotype

Glucocorticoid Receptor (GR) Expression in Human Tumors: A Tissue Microarray Study on More than 14,000 Tumors

A Tc1‐ and Th1‐T‐lymphocyte‐rich tumor microenvironment is a hallmark of MSI colorectal cancer

Deficiency of MTAP Is Frequent and Mostly Homogeneous in Pancreatic Ductal Adenocarcinomas

Stimulator of Interferon Genes Protein (STING) Expression in Cancer Cells: A Tissue Microarray Study Evaluating More than 18,000 Tumors from 139 Different Tumor Entities

Epithelial Cell Adhesion Molecule (EpCAM) Expression in Human Tumors: A Comparison with Pan-Cytokeratin and TROP2 in 14,832 Tumors

The 3-Biomarker Classifier—A Novel and Simple Molecular Risk Score Predicting Overall Survival in Patients with Colorectal Cancer

CD10 Expression Correlates with Earlier Tumour Stages and Left-Sided Tumour Location in Colorectal Cancer but Has No Prognostic Impact in a European Cohort

Frequency of Androgen Receptor Positivity in Tumors: A Study Evaluating More Than 18,000 Tumors

Carcinoembryonic Antigen Expression in Human Tumors: A Tissue Microarray Study on 13,725 Tumors

TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entities

Expression of Trefoil Factor 1 (TFF1) in Cancer: A Tissue Microarray Study Involving 18,878 Tumors

Mammaglobin-A Expression Is Highly Specific for Tumors Derived from the Breast, the Female Genital Tract, and the Salivary Gland

Automated Ki‐67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistry

BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1–driven Immune Phenotypes with Distinct Spatial Orchestration

Automated Prognosis Marker Assessment in Breast Cancers Using BLEACH&STAIN Multiplexed Immunohistochemistry

Diagnostic Role and Prognostic Impact of PSAP Immunohistochemistry: A Tissue Microarray Study on 31,358 Cancer Tissues

Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial Cells

Inhibin Alpha Expression in Human Tumors: A Tissue Microarray Study on 12,212 Tumors

T-Cell Density at the Invasive Margin and Immune Phenotypes Predict Outcome in Vulvar Squamous Cell Cancer

Large-scale human tissue analysis identifies Uroplakin 1b as a putative diagnostic marker in surgical pathology

Reduced CDH16 expression is linked to poor prognosis in clear cell renal cell carcinoma 16

Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligence

PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic Power

Collaborators (8)

Nikolaj Frost

Eik Vettorazzi

Sarah Weinberger

Maximilian Lennartz

Karsten Rippe

Aria Baniahmad

Tarik Ghadban

Niclas Christian Blessin

How do I reach out?

Meet Kite AI